Sessions

THE EXPONENTIAL GROWTH OF GENE THERAPY & IT’S FUTURE POTENTIAL
THE POTENTIAL & PROMISE OF ALLOGENEIC
THE CONTINUED RISE & APPLICATION OF AUTOLOGOUS THERAPIES

THE EXPONENTIAL GROWTH OF GENE THERAPY & IT’S FUTURE POTENTIAL

01 Sep 2022
11:00

11:00 – CHAIR INTRODUCTION

Chair: Uta Griesenbach, Professor of Molecular Medicine, National Heart and Lung Institute, Imperial College London

 

11:05 – CASE STUDY: GENE & CELL THERAPIES FOR RARE RESPIRATORY DISEASES

Speaker: Uta Griesenbach, Professor of Molecular Medicine, National Heart and Lung Institute, Imperial College London

 

11:25 – CASE STUDY: JOURNEY TO THE CENTRE OF THE GLOMERULUS   

Speaker: Alan Griffith, VP of Research, Purespring Therapeutics

 

11:45 – CASE STUDY:

PREPARING TO LAUNCH A GENE THERAPY FOR A RARE DISEASE IN THE UK; KEY LEARNINGS SO FAR

Speaker: Neil Dugdale, UK Country Lead, Gensight Biologics 

 

12:05 – Q&A WITH SESSION SPEAKERS

Speakers:

Alan Griffith, VP of Research, Purespring Therapeutics

Neil Dugdale, UK Country Lead, Gensight Biologics 

Speakers

Uta Griesenbach
Professor of Molecular Medicine, National Heart and Lung Institute
Imperial College London
Alan Griffith
Vice President of Research
PureSpring Therapeutics
Neil Dugdale
UK Country Lead
GenSight Biologics